-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/asthma-provider-adherence_executive.pdf
May 01, 2013 - Three studies—one RCT,65
one nonrandomized study66 and a controlled pre-post
study67—evaluated the … Seven studies evaluated the impact
of multicomponent interventions.77-83 All interventions
included … We identified one RCT58 and
one pre-post study63 that evaluated the effect of health
care provider … One study82 evaluated the impact of a
multicomponent intervention in pediatric clinics on rates
of … There were five studies that evaluated the
effect of health care provider education on missed school
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-240-acute-pain-evidence-summary.pdf
December 01, 2020 - Effect sizes were primarily small to moderate for pain, the most
commonly evaluated outcome. … Effects of traditional acupuncture
varied depending on the type of sham control evaluated. … Neck pain (5 trials): No trial evaluated pharmacologic therapy for acute neck pain.
-
effectivehealthcare-admin.ahrq.gov/products/hemorrhage-postpartum/clinician
December 01, 2019 - Several studies that were not included in this review evaluated medications in developing countries and … The interventions and outcomes evaluated were heterogeneous across studies. … A number of studies (not addressed in the current review) have evaluated such medications to prevent
-
effectivehealthcare-admin.ahrq.gov/products/integrated-pain-management/research
October 01, 2022 - We included 57 RCTs; 8 evaluated IPMPs and 49 evaluated CPMPs.
-
effectivehealthcare-admin.ahrq.gov/products/asthma-nonpharmacologic-treatment/research-indoor-allergen-reduction
October 01, 2019 - Studies were evaluated for risk of bias using the Cochrane Risk of Bias instrument or the Newcastle-Ottawa … Thirty-eight studies evaluated single component interventions.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/rapid-review-masks-prevention-covid-version-2.pdf
December 01, 2021 - Rather,
the RCTs were usually conducted during influenza season and evaluated the risk of nonspecific … Of the 15 studies that did control for confounders, only one23 evaluated correlations
between masks … Only one RCT directly compared different mask types.27 It evaluated a P2 mask (Australian
equivalent … Seven other trials, in addition to the trial described above, evaluated use of surgical masks
within … No study evaluated effects of extended or reuse of N95 respirators and risk of COVID-19.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-report-improving-health-systems-access.pdf
August 01, 2019 - EPCs developed, piloted, and evaluated nine products to facilitate dissemination or
implementation of … The three
different products were evaluated by members of the Johns Hopkins Health System using
a … Topic-relevant members of Strategic Clinical Networks
(SCNs) evaluated the summary documents using a … The quality measure indexes were evaluated by senior
leadership positions at Duke University Health … Final
pathway utilization was evaluated using metrics such as view rate.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/liver-cancer_disposition-comments.pdf
October 23, 2014 - We revised this statement to be more consistent with
our findings: “Few studies evaluated diagnostic … We revised this statement to be more consistent with
our findings: “Few studies evaluated diagnostic … It does not meet inclusion criteria because it
only evaluated patients with cholangiocarcinoma (no … on
sensitivity, though few studies evaluated this factor. … Fatty liver was not evaluated as a potential modifier of
diagnostic accuracy.
-
effectivehealthcare-admin.ahrq.gov/products/depression-treatment-ssri/research-protocol
December 01, 2019 - Summary of Revisions to Draft Key Questions :
The public comments were evaluated and discussed with … Harms associated with any of these interventions are evaluated in KQ2 and can include suicide, sexual … The study effects are evaluated in KQ1, 3 and 4, with the latter two questions considering subgroups … The study design elements evaluated with this tool include: selection of the study population, appropriate … These will be explicitly detailed for each outcome evaluated.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-272-genitourinary-syndrome-executive-summary.pdf
July 01, 2024 - • No studies evaluated the benefits or harms of screening for GSM, the timing of
evaluation for response … For
studies that evaluated non-hormonal interventions (other than vaginal moisturizers), we
created … No studies evaluated Key Questions related to GSM screening (KQ1) or directly
addressed appropriate … In 6 of 10 studies that evaluated endometrial stimulation
up to 36 weeks, vaginal estrogen was associated
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ems-911-workforce-mental-health-executive-summary.pdf
February 01, 2025 - Numbers in parentheses refer to numbers of studies that evaluated the modifying factor (row) for the … No studies evaluated modifying factors for the following
outcomes among telecommunicators: suicidality … Numbers in parentheses refer to numbers of studies that evaluated the modifying factor (row) for the … No studies evaluated modifying factors for the following
outcomes among Emergency Medical Services clinicians
-
effectivehealthcare-admin.ahrq.gov/products/patient-safety-telehealth/research
September 01, 2023 - Studies have evaluated the frequency and severity of harms associated with real-time video-based telehealth … No studies evaluated a specific PSP.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-193-naloxone-executive-summary.pdf
November 01, 2017 - • No study evaluated outcomes such as linkage to
treatment for opioid use disorder or subsequent … IN versus IV naloxone.39 No trial evaluated
the recently FDA-approved naloxone auto-injector for IM … No study evaluated the FDA-approved naloxone auto-
injector for IM administration, at either a dose of … Similarly, no
study evaluated the recently FDA-approved formulations
of highly-concentrated IN naloxone … One trial evaluated IN
naloxone at a concentration lower (2 mg/5 mL) than used
off-label in the United
-
effectivehealthcare-admin.ahrq.gov/products/acs-pci-adjunctive-devices/research-protocol
December 01, 2019 - infarction (STEMI)—has been less well supported mainly because of underpowered clinical trials that evaluated … recommendation). 2 More recently, larger randomized controlled trials of patients with STEMI have evaluated … Thus, the comparative efficacy and safety of these devices is unclear and needs to be systematically evaluated … Newly identified literature will be evaluated by two independent reviewers who will use the aforementioned … in more detail the features that will determine the strength of evidence for the different outcomes evaluated
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/coronary-artery-disease-testing_research-protocol.pdf
January 15, 2015 - Harms related to both
the initial test as well as subsequent testing will be evaluated. … Each study evaluated will be dual-reviewed for quality by two team members. … Harms
related to subsequent testing will be evaluated. … For these studies, only
the following hard clinical outcomes
will be evaluated: MI, heart failure, … will be evaluated based on studies
comparing two or more tests”
death.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/heart-failure-natriuretic-peptide_executive.pdf
November 01, 2013 - From these, 76 articles were evaluated for KQ1
and 28 for KQ2. … A total of nine articles were
evaluated for treatment guided by BNP or NT-proBNP
for KQ6. … Additionally, the majority of studies
(n = 50) evaluated all-cause mortality and composite
outcomes … Far fewer studies evaluated
longer term prognosis (>12 months), and these studies
measured admission … In the two
studies in which healthy individuals were evaluated, the
RCVs were higher than those in
-
effectivehealthcare-admin.ahrq.gov/products/health-equity-preventive/research
January 01, 2021 - Key Messages No eligible studies evaluated effects of provider barriers. … No eligible studies evaluated effects of provider-specific barriers; 18 studies of population barriers
-
effectivehealthcare-admin.ahrq.gov/products/hypertension-pulmonary-arterial/research
December 01, 2019 - Results
Sixty studies involving 7,096 patients evaluated biomarker tests, echocardiography, or both … Ninety-nine studies involving 8,655 patients evaluated biomarker tests, echocardiography, or both to
-
effectivehealthcare-admin.ahrq.gov/products/horizon-scan/research
July 01, 2019 - Finally, we evaluated the variability in the high-impact potential (HIP) assessments using the metric … We also evaluated the usability of the HIP assessment through the stakeholder survey.
-
effectivehealthcare-admin.ahrq.gov/products/coronary-artery-stenting/research
December 01, 2019 - We evaluated therapeutic decisionmaking outcomes, intermediate outcomes, and patient-centered outcomes … Data synthesis
In total, 37 eligible studies evaluated two of the intravascular diagnostic techniques